Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Dedicated optoelectronic stochastic parallel processor for real-time image processing: motion-detection demonstration and design of a hybrid complementary-metal-oxide semiconductor- self-electro-optic-device-based prototype.

Applied optics

Cassinelli A, Chavel P, Desmulliez MP.
PMID: 18364956
Appl Opt. 2001 Dec 10;40(35):6479-91. doi: 10.1364/ao.40.006479.

We report experimental results and performance analysis of a dedicated optoelectronic processor that implements stochastic optimization-based image-processing tasks in real time. We first show experimental results using a proof-of-principle-prototype demonstrator based on standard silicon-complementary-metal-oxide-semiconductor (CMOS) technology and liquid-crystal spatial...

Cite
Cassinelli A, Chavel P, Desmulliez MP. Dedicated optoelectronic stochastic parallel processor for real-time image processing: motion-detection demonstration and design of a hybrid complementary-metal-oxide semiconductor- self-electro-optic-device-based prototype. Appl Opt. 2001;40(35):6479-91doi: 10.1364/ao.40.006479.
Cassinelli, A., Chavel, P., & Desmulliez, M. P. (2001). Dedicated optoelectronic stochastic parallel processor for real-time image processing: motion-detection demonstration and design of a hybrid complementary-metal-oxide semiconductor- self-electro-optic-device-based prototype. Applied optics, 40(35), 6479-91. https://doi.org/10.1364/ao.40.006479
Cassinelli, A, et al. "Dedicated optoelectronic stochastic parallel processor for real-time image processing: motion-detection demonstration and design of a hybrid complementary-metal-oxide semiconductor- self-electro-optic-device-based prototype." Applied optics vol. 40,35 (2001): 6479-91. doi: https://doi.org/10.1364/ao.40.006479
Cassinelli A, Chavel P, Desmulliez MP. Dedicated optoelectronic stochastic parallel processor for real-time image processing: motion-detection demonstration and design of a hybrid complementary-metal-oxide semiconductor- self-electro-optic-device-based prototype. Appl Opt. 2001 Dec 10;40(35):6479-91. doi: 10.1364/ao.40.006479. PMID: 18364956.
Copy Download .nbib Format: NLM
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer.

Oncology reports

Santinami M, Cascinelli F, Chiti A, Galluzzo D, Inglese M, Delia F, Santoro N, Sequeira C, Vaglini M, Deraco M.
PMID: 21594516
Oncol Rep. 1996 Nov;3(6):1097-102. doi: 10.3892/or.3.6.1097.

Twenty-eight patients affected by non-resectable pelvic recurrence of a primary pelvic malignant neoplasm were treated by isolated pelvic perfusion, at mean hyperthermia, with different drugs, chosen taking into account tumor chemosensitivity. All patients had been previously treated. Four complete...

Cite
Santinami M, Cascinelli F, Chiti A, et al. Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer. Oncol Rep. 1996;3(6):1097-102doi: 10.3892/or.3.6.1097.
Santinami, M., Cascinelli, F., Chiti, A., Galluzzo, D., Inglese, M., Delia, F., Santoro, N., Sequeira, C., Vaglini, M., & Deraco, M. (1996). Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer. Oncology reports, 3(6), 1097-102. https://doi.org/10.3892/or.3.6.1097
Santinami, M, et al. "Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer." Oncology reports vol. 3,6 (1996): 1097-102. doi: https://doi.org/10.3892/or.3.6.1097
Santinami M, Cascinelli F, Chiti A, Galluzzo D, Inglese M, Delia F, Santoro N, Sequeira C, Vaglini M, Deraco M. Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer. Oncol Rep. 1996 Nov;3(6):1097-102. doi: 10.3892/or.3.6.1097. PMID: 21594516.
Copy Download .nbib Format: NLM
Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma.

Cancers

Lanzi C, Dal Bo L, Favini E, Tortoreto M, Beretta GL, Arrighetti N, Zaffaroni N, Cassinelli G.
PMID: 30909453
Cancers (Basel). 2019 Mar 22;11(3). doi: 10.3390/cancers11030408.

Pazopanib is approved for treatment of advanced soft tissue sarcomas, but primary and secondary drug resistance limits its clinical utility. We investigated the molecular mechanisms mediating pazopanib resistance in human synovial sarcoma (SS) models. We found reduced cell sensitivity...

Cite
Lanzi C, Dal Bo L, Favini E, et al. Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma. Cancers (Basel). 2019;11(3)doi: 10.3390/cancers11030408.
Lanzi, C., Dal Bo, L., Favini, E., Tortoreto, M., Beretta, G. L., Arrighetti, N., Zaffaroni, N., & Cassinelli, G. (2019). Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma. Cancers, 11(3), . https://doi.org/10.3390/cancers11030408
Lanzi, Cinzia, et al. "Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma." Cancers vol. 11,3 (2019). doi: https://doi.org/10.3390/cancers11030408
Lanzi C, Dal Bo L, Favini E, Tortoreto M, Beretta GL, Arrighetti N, Zaffaroni N, Cassinelli G. Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma. Cancers (Basel). 2019 Mar 22;11(3). doi: 10.3390/cancers11030408. PMID: 30909453; PMCID: PMC6468361.
Copy Download .nbib Format: NLM
Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies.

Methods in molecular biology (Clifton, N.J.)

Bernasconi A, Cascianelli S.
PMID: 34902130
Methods Mol Biol. 2022;2401:195-215. doi: 10.1007/978-1-0716-1839-4_13.

The COVID-19 pandemic has hit heavily many aspects of our lives. At this time, genomic research is concerned with exploiting available datasets and knowledge to fuel discovery on this novel disease. Studies that can precisely characterize the gene expression...

Cite
Bernasconi A, Cascianelli S. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods Mol Biol. 2022;2401:195-215doi: 10.1007/978-1-0716-1839-4_13.
Bernasconi, A., & Cascianelli, S. (2022). Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods in molecular biology (Clifton, N.J.), 2401195-215. https://doi.org/10.1007/978-1-0716-1839-4_13
Bernasconi, Anna, and Cascianelli, Silvia. "Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies." Methods in molecular biology (Clifton, N.J.) vol. 2401 (2022): 195-215. doi: https://doi.org/10.1007/978-1-0716-1839-4_13
Bernasconi A, Cascianelli S. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods Mol Biol. 2022;2401:195-215. doi: 10.1007/978-1-0716-1839-4_13. PMID: 34902130.
Copy Download .nbib Format: NLM
Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study.

Surgical endoscopy

Castro A, Cassinello N, Alfonso R, Ortega J.
PMID: 33523271
Surg Endosc. 2022 Jan;36(1):430-434. doi: 10.1007/s00464-021-08302-7. Epub 2021 Feb 01.

BACKGROUND: Although a reliable procedure in morbid obesity treatment, bariatric surgery may be associated with serious complications such as leakage or bleeding. We aimed to analyze the preoperative factors involved in patients with early postoperative hemorrhage after any type...

Cite
Castro A, Cassinello N, Alfonso R, et al. Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surg Endosc. 2021;36(1):430-434doi: 10.1007/s00464-021-08302-7.
Castro, A., Cassinello, N., Alfonso, R., & Ortega, J. (2022). Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surgical endoscopy, 36(1), 430-434. https://doi.org/10.1007/s00464-021-08302-7
Castro, Andrés, et al. "Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study." Surgical endoscopy vol. 36,1 (2022): 430-434. doi: https://doi.org/10.1007/s00464-021-08302-7
Castro A, Cassinello N, Alfonso R, Ortega J. Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surg Endosc. 2022 Jan;36(1):430-434. doi: 10.1007/s00464-021-08302-7. Epub 2021 Feb 01. PMID: 33523271.
Copy Download .nbib Format: NLM
Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study.

Surgical endoscopy

Castro A, Cassinello N, Alfonso R, Ortega J.
PMID: 33523271
Surg Endosc. 2021 Feb 01; doi: 10.1007/s00464-021-08302-7. Epub 2021 Feb 01.

BACKGROUND: Although a reliable procedure in morbid obesity treatment, bariatric surgery may be associated with serious complications such as leakage or bleeding. We aimed to analyze the preoperative factors involved in patients with early postoperative hemorrhage after any type...

Cite
Castro A, Cassinello N, Alfonso R, et al. Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surg Endosc. 2021;doi: 10.1007/s00464-021-08302-7.
Castro, A., Cassinello, N., Alfonso, R., & Ortega, J. (2021). Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surgical endoscopy, . https://doi.org/10.1007/s00464-021-08302-7
Castro, Andrés, et al. "Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study." Surgical endoscopy vol. (2021). doi: https://doi.org/10.1007/s00464-021-08302-7
Castro A, Cassinello N, Alfonso R, Ortega J. Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study. Surg Endosc. 2021 Feb 01; doi: 10.1007/s00464-021-08302-7. Epub 2021 Feb 01. PMID: 33523271.
Copy Download .nbib Format: NLM
Human orf complicated with erythema multiforme. A neglected disease in Italian woman.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia

Uccella I, Fabrizi P, Dell'uomo V, Casinelli K, Lunghi F.
PMID: 31302981
G Ital Dermatol Venereol. 2019 Jul 12; doi: 10.23736/S0392-0488.19.06389-2. Epub 2019 Jul 12.

No abstract available.

Cite
Uccella I, Fabrizi P, Dell'uomo V, et al. Human orf complicated with erythema multiforme. A neglected disease in Italian woman. G Ital Dermatol Venereol. 2019;doi: 10.23736/S0392-0488.19.06389-2.
Uccella, I., Fabrizi, P., Dell'uomo, V., Casinelli, K., & Lunghi, F. (2019). Human orf complicated with erythema multiforme. A neglected disease in Italian woman. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, . https://doi.org/10.23736/S0392-0488.19.06389-2
Uccella, Ilaria, et al. "Human orf complicated with erythema multiforme. A neglected disease in Italian woman." Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia vol. (2019). doi: https://doi.org/10.23736/S0392-0488.19.06389-2
Uccella I, Fabrizi P, Dell'uomo V, Casinelli K, Lunghi F. Human orf complicated with erythema multiforme. A neglected disease in Italian woman. G Ital Dermatol Venereol. 2019 Jul 12; doi: 10.23736/S0392-0488.19.06389-2. Epub 2019 Jul 12. PMID: 31302981.
Copy Download .nbib Format: NLM
Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties.

Journal of functional biomaterials

Iviglia G, Torre E, Cassinelli C, Morra M.
PMID: 34063147
J Funct Biomater. 2021 May 05;12(2). doi: 10.3390/jfb12020031.

Oral diseases and periodontitis in particular are a major health burden worldwide, because of their association with various systemic diseases and with conditions such as peri-implantitis. Attempts have been made over the years to reverse bone loss due to...

Cite
Iviglia G, Torre E, Cassinelli C, et al. Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties. J Funct Biomater. 2021;12(2)doi: 10.3390/jfb12020031.
Iviglia, G., Torre, E., Cassinelli, C., & Morra, M. (2021). Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties. Journal of functional biomaterials, 12(2), . https://doi.org/10.3390/jfb12020031
Iviglia, Giorgio, et al. "Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties." Journal of functional biomaterials vol. 12,2 (2021). doi: https://doi.org/10.3390/jfb12020031
Iviglia G, Torre E, Cassinelli C, Morra M. Functionalization with a Polyphenol-Rich Pomace Extract Empowers a Ceramic Bone Filler with In Vitro Antioxidant, Anti-Inflammatory, and Pro-Osteogenic Properties. J Funct Biomater. 2021 May 05;12(2). doi: 10.3390/jfb12020031. PMID: 34063147; PMCID: PMC8167574.
Copy Download .nbib Format: NLM
Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies.

Methods in molecular biology (Clifton, N.J.)

Bernasconi A, Cascianelli S.
PMID: 34902130
Methods Mol Biol. 2022;2401:195-215. doi: 10.1007/978-1-0716-1839-4_13.

The COVID-19 pandemic has hit heavily many aspects of our lives. At this time, genomic research is concerned with exploiting available datasets and knowledge to fuel discovery on this novel disease. Studies that can precisely characterize the gene expression...

Cite
Bernasconi A, Cascianelli S. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods Mol Biol. 2022;2401:195-215doi: 10.1007/978-1-0716-1839-4_13.
Bernasconi, A., & Cascianelli, S. (2022). Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods in molecular biology (Clifton, N.J.), 2401195-215. https://doi.org/10.1007/978-1-0716-1839-4_13
Bernasconi, Anna, and Cascianelli, Silvia. "Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies." Methods in molecular biology (Clifton, N.J.) vol. 2401 (2022): 195-215. doi: https://doi.org/10.1007/978-1-0716-1839-4_13
Bernasconi A, Cascianelli S. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies. Methods Mol Biol. 2022;2401:195-215. doi: 10.1007/978-1-0716-1839-4_13. PMID: 34902130.
Copy Download .nbib Format: NLM
Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy.

Radiology case reports

Casinelli A, Malavolta G, Caruso G, Capri O, Ballesio L.
PMID: 34429812
Radiol Case Rep. 2021 Aug 14;16(10):3104-3108. doi: 10.1016/j.radcr.2021.07.019. eCollection 2021 Oct.

Breast imaging screening during lactation poses a real clinical challenge, especially in high-risk patients. We presented the case of a 34-year-old BRCA1-mutated woman showing marked, asymmetric background parenchymal enhancement on the right breast suspicious for malignancy in the context...

Cite
Casinelli A, Malavolta G, Caruso G, et al. Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy. Radiol Case Rep. 2021;16(10):3104-3108doi: 10.1016/j.radcr.2021.07.019.
Casinelli, A., Malavolta, G., Caruso, G., Capri, O., & Ballesio, L. (2021). Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy. Radiology case reports, 16(10), 3104-3108. https://doi.org/10.1016/j.radcr.2021.07.019
Casinelli, Alice, et al. "Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy." Radiology case reports vol. 16,10 (2021): 3104-3108. doi: https://doi.org/10.1016/j.radcr.2021.07.019
Casinelli A, Malavolta G, Caruso G, Capri O, Ballesio L. Breast imaging screening in a BRCA1-mutated lactating patient: A potential pitfall mimicking malignancy. Radiol Case Rep. 2021 Aug 14;16(10):3104-3108. doi: 10.1016/j.radcr.2021.07.019. eCollection 2021 Oct. PMID: 34429812; PMCID: PMC8367808.
Copy Download .nbib Format: NLM
Molecular mechanisms of resistance to taxanes and therapeutic implications.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Zunino F, Cassinelli G, Polizzi D, Perego P.
PMID: 11498350
Drug Resist Updat. 1999 Dec;2(6):351-357. doi: 10.1054/drup.1999.0108.

The mechanism of resistance to taxanes has not been fully elucidated. Since Taxol is a substrate for P-glycoprotein, overexpression of this transport system is recognized as a relevant mechanism of resistance. Additional mechanisms include changes of microtubule structure and/or...

Cite
Zunino F, Cassinelli G, Polizzi D, et al. Molecular mechanisms of resistance to taxanes and therapeutic implications. Drug Resist Updat. 1999;2(6):351-357doi: 10.1054/drup.1999.0108.
Zunino, F., Cassinelli, G., Polizzi, D., & Perego, P. (1999). Molecular mechanisms of resistance to taxanes and therapeutic implications. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2(6), 351-357. https://doi.org/10.1054/drup.1999.0108
Zunino, Franco, et al. "Molecular mechanisms of resistance to taxanes and therapeutic implications." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 2,6 (1999): 351-357. doi: https://doi.org/10.1054/drup.1999.0108
Zunino F, Cassinelli G, Polizzi D, Perego P. Molecular mechanisms of resistance to taxanes and therapeutic implications. Drug Resist Updat. 1999 Dec;2(6):351-357. doi: 10.1054/drup.1999.0108. PMID: 11498350.
Copy Download .nbib Format: NLM
The Incorporation of Strontium to Improve Bone-Regeneration Ability of Mesoporous Bioactive Glasses.

Materials (Basel, Switzerland)

Fiorilli S, Molino G, Pontremoli C, Iviglia G, Torre E, Cassinelli C, Morra M, Vitale-Brovarone C.
PMID: 29701683
Materials (Basel). 2018 Apr 26;11(5). doi: 10.3390/ma11050678.

Over the recent years, mesoporous bioactive glasses (MBGs) gained interest as bone regeneration systems, due to their excellent bioactivity and ability to release therapeutic molecules. In order to improve the bone regeneration ability of MBGs, the incorporation of Sr

Cite
Fiorilli S, Molino G, Pontremoli C, et al. The Incorporation of Strontium to Improve Bone-Regeneration Ability of Mesoporous Bioactive Glasses. Materials (Basel). 2018;11(5)doi: 10.3390/ma11050678.
Fiorilli, S., Molino, G., Pontremoli, C., Iviglia, G., Torre, E., Cassinelli, C., Morra, M., & Vitale-Brovarone, C. (2018). The Incorporation of Strontium to Improve Bone-Regeneration Ability of Mesoporous Bioactive Glasses. Materials (Basel, Switzerland), 11(5), . https://doi.org/10.3390/ma11050678
Fiorilli, Sonia, et al. "The Incorporation of Strontium to Improve Bone-Regeneration Ability of Mesoporous Bioactive Glasses." Materials (Basel, Switzerland) vol. 11,5 (2018). doi: https://doi.org/10.3390/ma11050678
Fiorilli S, Molino G, Pontremoli C, Iviglia G, Torre E, Cassinelli C, Morra M, Vitale-Brovarone C. The Incorporation of Strontium to Improve Bone-Regeneration Ability of Mesoporous Bioactive Glasses. Materials (Basel). 2018 Apr 26;11(5). doi: 10.3390/ma11050678. PMID: 29701683; PMCID: PMC5978055.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries